XBiotech Inc. — Balance Sheet Charts
20 snapshots of history · ending 2023-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↓-7.9% -$19M
$227M
Current Assets↓-8.2% -$18M
$202M
Cash & Equivalents↑+27.2% +$43M
$200M
ST Investments↓-100.0% -$60M
$0
Receivables↓-29.3% -$356K
$860K
Net PPE↓-5.2% -$1M
$25M
Total Liabilities↑+36.3% +$2M
$8M
Current Liabilities↑+50.0% +$2M
$6M
Account Payables↑+4.5% +$108K
$3M
Stockholders Equity↓-9.0% -$22M
$219M
Retained Earnings↓-88.5% -$25M
$-52M
Accumulated Depreciation↑+21.2% +$3M
$20M
Contract Liability↓-100.0% -$5M
$0
Contract Liability (Current)↓-100.0% -$5M
$0